Anfield Capital Management, LLC Ampio Pharmaceuticals, Inc. Call Options Transaction History
Anfield Capital Management, LLC
- $255 Million
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AMPE
# of Institutions
1Shares Held
96.6KCall Options Held
0Put Options Held
0About Ampio Pharmaceuticals, Inc.
- Ticker AMPE
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 226,287,008
- Description
- Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...